Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVX001 topical ointment in mild to moderate plaque psoriasis
2014-004467-20Phase 2Completed
- Sponsor
- Avexxin AS
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of AVX001 in plaque psoriasis (4 arms), sponsored by Avexxin AS. Primary endpoint: Rate of patients with severe local skin reaction adverse events. Started Dec 2014; status: completed.
02
Drugs
AVX001
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2014-004467-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004467-20.